Last edition
News about Biotechnology
Lilly’s acquisition of Orna Therapeutics aims to accelerate development of in vivo CAR-T therapies powered by engineered circular RNA and advanced lipid nanoparticle delivery platforms.
Biotechnology | 10/02/2026 | By News Bureau | 209
This collaboration with Frontier Space provides an opportunity for Azenta to demonstrate how its sample management technologies perform in demanding research environments, helping extend use of its high-precision consumables into new research settings and next-generation workflows, further reinforcing the company's leadership in sample integrity.
Biotechnology | 10/02/2026 | By News Bureau | 104
FUJIFILM Biotechnologies Enhances UK Manufacturing with Advanced Downstream Purification System
FUJIFILM Biotechnologies has announced plans to deploy its proprietary downstream purification system at its manufacturing facility in the United Kingdom, aiming to enhance production efficiency and expand biopharmaceutical processing capabilities.
Biotechnology | 09/02/2026 | By Darshana | 123
Slingshot Backs New Precision Oncology Venture from Crick Research
Slingshot Therapeutics, Syncona’s accelerator platform for advancing early-stage drug discovery programmes, has launched ALTx Therapeutics with an initial £12.55 million funding commitment from Syncona, the Francis Crick Institute, and Cancer Research Horizons.
Biotechnology | 07/02/2026 | By Darshana | 170
Japan Patent Boosts Marvel's Neurology Pipeline for MB-204
Marvel Biosciences Corporation, through its subsidiary Marvel Biotechnology Inc., has secured a key intellectual property milestone after the Japan Patent Office granted a patent covering its lead therapeutic candidate, MB-204.
Biotechnology | 05/02/2026 | By Darshana | 147
UK Industry Body Finds Sanofi in Breach Over RSV Therapy Claims Against Pfizer
A UK pharmaceutical industry watchdog has ruled that Sanofi breached the country’s code of practice by making misleading claims about its respiratory syncytial virus (RSV) therapy in comparison with a rival product from Pfizer.
Biotechnology | 04/02/2026 | By Darshana | 192
Tenacia and Golden Age Health Partner to Commercialise Ztalmy for CDKL5 Deficiency Disorder in China
Tenacia Biopharmaceuticals has granted Golden Age Health exclusive rights to commercialise Ztalmy, the first approved therapy for CDKL5 deficiency disorder, in Mainland China.
Biotechnology | 03/02/2026 | By News Bureau | 196
Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology at Indian Manufacturing Sites
Piramal Pharma Solutions has successfully developed and commercialised a tablet-in-capsule drug delivery system in India, enabling flexible dosing, dual-release profiles and improved patient-centric oral therapies.
Biotechnology | 03/02/2026 | By News Bureau | 194
USA Biomanufacturing Investment Surges Nearly 20 Percent, Report Finds
Investment in biomanufacturing across the USA has recorded a sharp rise, with pledged capital increasing by nearly 20 percent since 2024, according to a recent industry report. The surge positions biomanufacturing as one of the fastest-growing segments within the country’s advanced manufacturing landscape.
<br />
Biotechnology | 31/01/2026 | By Darshana | 206
Defence Therapeutics Advances Precision Radiopharmaceutical Development with CNL
Defence Therapeutics Inc., a publicly traded biotechnology company focused on precision intracellular drug delivery, has announced an expansion of its long-standing collaboration with Canadian Nuclear Laboratories (CNL) to accelerate the development of its radiopharmaceutical pipeline.
Biotechnology | 30/01/2026 | By Darshana | 129
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy